New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 16, 2012
10:07 EDTGMCR, SDRL, GPS, OSIS, ROP, MYL, GME, RFOn The Fly: Analysts Upgrade Summary
Today's noteworthy upgrades include: Gap (GPS) upgraded to Hold from Sell at Canaccord...Regions Financial (RF) upgraded to Outperform from Neutral at RW Baird...Roper Industries (ROP) upgraded to Buy from Neutral at Citigroup...Seadrill (SDRL) upgraded to Outperform from Neutral at Credit Suisse...GameStop (GME) upgraded to Buy from Above Average at Caris...OSI Systems (OSIS) upgraded to Outperform from Perform at Oppenheimer...Green Mountain (GMCR) upgraded to Buy from Neutral at Dougherty...Mylan (MYL) upgraded to Outperform from Market Perform at Leerink.
News For GPS;RF;ROP;SDRL;GME;OSIS;GMCR;MYL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
July 23, 2015
09:04 EDTMYLTeva says 'strongly disagrees' with Stichting stated analysis
Teva Pharmaceutical Industries (TEVA) issued the following statement regarding Stichting Preferred Shares Mylan’s (MYL) decision to exercise its call option: "We strongly disagree with the stated analysis of Stichting Preferred Shares Mylan and its decision to exercise its call option, which is unwarranted, relies on false assumptions, and risks depriving Mylan stockholders and other stakeholders of the value inherent in a combination of Teva and Mylan. We continue to believe that our proposed transaction offers a compelling opportunity for value-creation and many other benefits for the stockholders, customers, patients, and employees of both companies. We are well advised on Dutch law, including the ability of Mylan stockholders to challenge this action in court, and are prepared to take the necessary actions at the appropriate time."
08:48 EDTMYLMylan, Teva lower after Stitching looks to thwart hostile deal
Subscribe for More Information
08:48 EDTMYLMylan confirms exercise of full call option by independent foundation
Subscribe for More Information
08:34 EDTMYLMylan foundation exercises call option to 'level playing field'
08:33 EDTMYLMylan foundation says shareholders at risk of Teva takeover
Subscribe for More Information
July 22, 2015
10:06 EDTMYLAbbott CEO says supportive of Mylan pursuit of Perrigo
Subscribe for More Information
10:01 EDTRFOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:37 EDTRFRegions Financial downgraded to Hold from Buy at Sandler O'Neill
09:30 EDTMYLAbbott CEO says 'pretty alligned' with Mylan so far
July 21, 2015
10:01 EDTGMCROn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:04 EDTOSISOSI Systems receives $15M follow-on order for inspection systems
OSI Systems announced that its Security division, Rapiscan Systems, received a follow-on order, valued at approximately $15M, from a Middle East government to provide additional Baggage and Parcel Inspection and Eagle Cargo and Vehicle Inspection systems for port and border protection.
06:07 EDTGPSONUG: Yahoo hires VP of global network from Symantec
Subscribe for More Information
06:02 EDTRFRegions Financial reports Q2 ending loans totaled $80B, up 5% from last year
Subscribe for More Information
06:00 EDTRFRegions Financial reports Q2 EPS 20c, consensus 20c
Subscribe for More Information
05:57 EDTGMCRStocks with implied volatility above IV index mean; CMG GMCR
Subscribe for More Information
July 20, 2015
16:40 EDTGMCRKeurig Green Mountain initiated with a Neutral at Sterne Agee CRT
15:01 EDTRFNotable companies reporting before tomorrow's open
Subscribe for More Information
08:38 EDTMYLAnalyst predicts Zoetis merges with Bayer unit, not Valeant
Zoetis (ZTS) in recent months has been the subject of takeover speculation, possibly for Valeant (VRX), but a Jefferies analyst told investors today in a research note that he views a deal with a unit of healthcare giant Bayer (BAYRY) as "highly likely" for the animal medicine company. BACKGROUND: Bill Ackman of Pershing Square, who owns stakes in both Zoetis and Valeant, said in early May while speaking on CNBC that Zoetis is a "great” business on a standalone basis, but he also spoke of the company's strategic value. Ackman added, however, that he was "not sure" that Valeant was the best acquirer of Zoetis. Subsequently, in late June, The Wall Street Journal reported that Valeant made a preliminary approach regarding a potential deal to buy Zoetis. CNBC's David Faber said the next day, citing his own sources, that Valeant reached out to Zoetis as a courtesy to common shareholder Ackman and was unlikely to pursue an acquisition of the company, though he cautioned then Valeant could change its approach and pursue a deal. BAYER: Jefferies analyst Jeffrey Holford said in a note today that he views a tie-up between Zoetis and Bayer's Animal Health business in 2016 as "highly likely." He sees Mylan's (MYL) acquisition of Abbott's (ABT) non‑U.S. developed markets specialty and branded generics business as a potential proxy for how a transaction could be structured, adding that such a "spinversion" could achieve up to 36% long-term earnings accretion for Zoetis. Holford reiterated a Buy rating on Zoetis with a $60 price target, while downgrading Bayer to Hold, citing valuation following the recent outperformance of its shares. IDEXX: While being discussed as a target, some analysts have also opined on companies that Zoetis could pursue as a buyer. On June 29, Canaccord said that in investor meetings with IDEXX (IDXX) executives declined to comment on Zoetis' potential interest in scaling up its animal health diagnostics business. Canaccord added that it thought Zoetis could make a bid for IDEXX. The firm reiterated its Buy rating and $80 price target on IDEXX shares at that time. PRICE ACTION: Since June 25, the day the Journal first reported on Valeant's preliminary takeover approach to Zoetis, the animal health company's shares have dropped nearly 4%. Zoetis closed down 20c to $47.80 on Friday.
07:33 EDTMYLInternational AIDS Society to hold a conference
Subscribe for More Information
07:30 EDTMYLZoetis 'highly likely' to merge with Bayer unit in 2016, says Jefferies
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use